Coumarin-like cyclic compound as MEK inhibitor and use thereof
US11021486B2 · kind B2 · utility
0Cited by
0References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 22, 2018 |
| Grant date | Jun 1, 2021 |
| Priority date | — |
| Expiry date | Jun 22, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are a class of coumarin-like cyclic compounds as MEK inhibitors and pharmaceutical compositions comprising the compounds, and the use of same in the preparation of a drug for treating MEK-related diseases. Particularly disclosed are compounds as shown in formula (I) and pharmaceutically acceptable salts thereof or tautomers thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.